Nestle Recalls Limited Batches of Baby Formula in Uzbekistan

Nestle Food LLC has announced a voluntary recall of a limited number of infant nutrition products in Uzbekistan as a precautionary measure. The company cited a potential safety risk linked to a raw ingredient supplied by a third party.

The recall affects specific batches of powdered instant milk and fermented milk formulas, as well as an amino acid-based medical nutrition product sold under the NAN and ALFARÉ brands. According to the company, the action forms part of a wider global recall of certain infant nutrition products initiated by Nestle.

Possible toxin linked to raw material supplier

Nestle said the move was prompted by the possible presence of cereulide, a toxin produced by some strains of Bacillus cereus, in arachidonic acid sourced from an external supplier. While the ingredient is used in very small quantities and cereulide is not currently regulated in food products in Uzbekistan, the company said it decided to act in line with its global safety standards.

From January 5, 2026, Nestle Food LLC began withdrawing the affected batches from sale in Uzbekistan. The company stressed that the recall is precautionary and conducted in accordance with its internal quality and safety protocols. Products from other batches and other Nestle infant nutrition items sold in the country are not affected.

Consumer guidance and international scope

Nestle said it has informed regulators and is ready to provide consumers and partners with full details about the recall. Customers who purchased the affected products will be able to return them under procedures set out by the company. A consumer support hotline has also been made available.

Globally, Nestle confirmed that no illnesses have been reported in connection with the recalled products. The company said it has completed testing of all potentially affected arachidonic acid oil, switched to alternative suppliers and increased production at several factories to limit supply disruption.

The recall covers products sold mainly in Europe as well as in Turkey, Uzbekistan, Kazakhstan and Argentina. Cereulide is resistant to heat and cannot be destroyed by boiling water during formula preparation, according to food safety authorities, and can cause rapid-onset symptoms such as vomiting and stomach cramps.

Nestle holds nearly a quarter of the global infant nutrition market, estimated at more than $92 bn, according to industry data. Infant formula forms part of its Nutrition and Health Science division, which accounted for about 16.6% of the group’s total sales in 2024.

Kursiv also reports that last year Nestle has withdrawn from a global initiative designed to reduce methane emissions in the dairy sector.